cetuximab,cisplatin
eli lilly
['cetuximab', 'cisplatin']
spanish rwd on taxol-cetuximab in &gt;500 hnscc patients that are frail, cisplatin inelegible and/or refractory - this is a real option for this patient population. #esmo2022 #oncoalert 
Medical Oncologist. Head and Neck Cancer and Early Drug Development. Currently at Catalan Institute of Oncology. Former PMH DDP Fellow. Opinions are my own.